NOMURA RESEARCH INSTITUTE LTD.NOMURA RESEARCH INSTITUTE LTD.NOMURA RESEARCH INSTITUTE LTD.

NOMURA RESEARCH INSTITUTE LTD.

No trades
See on Supercharts
Market capitalization
‪14.11 B‬EUR
‪529.95 M‬EUR
‪4.81 B‬EUR
‪387.36 M‬
Beta (1Y)
1.02

About NOMURA RESEARCH INSTITUTE LTD.

CEO
Kaga Yanagisawa
Website
Headquarters
Tokyo
Employees (FY)
‪17.39 K‬
Founded
1965
ISIN
JP3762800005
FIGI
BBG000M57SS4
Nomura Research Institute Ltd. engages in the provision of research, business consulting, and systems services. It operates through the following segments: Consulting, Financial Information Technology (IT) Solutions, Industrial IT Solutions, and IT Platform Services. The Consulting segment provides management and systems consulting services. The Financial IT Solutions segment offers IT solutions for securities, banking, and insurance sectors. The Industrial IT Solutions segment deals with IT solutions and infrastructure services for distribution, manufacturing, service, and healthcare industries, as well as for government and other public agencies. The IT Platform Services segment handles data center operation management, IT infrastructure, and network construction. It also conducts research for the development of new business operations and new products related to IT solutions. The company was founded on April 1, 1965 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange NOMURA RESEARCH INSTITUTE LTD. stocks are traded under the ticker NR7.
NOMURA RESEARCH INSTITUTE LTD. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for NOMURA RESEARCH INSTITUTE LTD. has a max estimate of 31.115 EUR and a min estimate of 23.185 EUR.
NR7 earnings for the last quarter are 0.22 EUR whereas the estimation was 0.21 EUR which accounts for 3.52% surprise. Estimated earnings for the next quarter are 0.24 EUR. See more details about NOMURA RESEARCH INSTITUTE LTD. earnings.
NOMURA RESEARCH INSTITUTE LTD. revenue for the last quarter amounts to ‪1.17 B‬ EUR despite the estimated figure of ‪1.15 B‬ EUR. In the next quarter revenue is expected to reach ‪1.21 B‬ EUR.
Yes, you can track NOMURA RESEARCH INSTITUTE LTD. financials in yearly and quarterly reports right on TradingView.
Like other stocks, NR7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOMURA RESEARCH INSTITUTE LTD. stock right from TradingView charts — choose your broker and connect to your account.
NR7 reached its all-time high on Dec 16, 2021 with the price of 39.000 EUR, and its all-time low was 2.395 EUR and was reached on Mar 11, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪17.39 K‬ employees. See our rating of the largest employees — is NOMURA RESEARCH INSTITUTE LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOMURA RESEARCH INSTITUTE LTD. EBITDA is ‪1.06 B‬ EUR, and current EBITDA margin is 22.26%. See more stats in NOMURA RESEARCH INSTITUTE LTD. financial statements.